Navigation Links
Protein that controls hair growth also keeps stem cells slumbering
Date:1/24/2008

Like fine china and crystal, which tend to be used sparingly, stem cells divide infrequently. It was thought they did so to protect themselves from unnecessary wear and tear. But now new research from Rockefeller University has unveiled the protein that puts the brakes on stem cell division and shows that stem cells may not need such guarded protection to maintain their potency.

This research, to be published in the January 25 issue of Cell, raises questions about what stem cells need in order to maintain their ability to regenerate tissue. It may also be key in developing new treatments for thinning hair.

The impetus for the work began five years ago when Elaine Fuchs, head of the Laboratory of Mammalian Cell Biology and Development, and several researchers in her lab discovered that the protein NFATc1 was one of only a few that are highly expressed within the stem cell compartment of the hair follicle. Clinical research, meanwhile, showed that a particular immunosuppressant that inhibits NFATc1, a drug called cyclosporine A, has a rather unsightly side effect: excessive hair growth.

Fuchs and Valerie Horsley, a postdoc in her lab, realized that there was a connection between the drug's side effect and the abundance of NFATc1 within the hair follicle's stem cell compartment -- the bulge. The mice they treated with the drug grew fur at a much faster rate than mice they did not treat. The researchers then showed that this excessive hair growth was due to increased stem cell activity within the bulge, a process that cranked up the production of hair. Specifically, the hair cycle shifted gears from its resting phase, when stem cells slumber, to its growth phase, when stem cells proliferate.

To maintain their multipotent properties, though, it appears that these stem cells hardly needed much "rest" at all. These findings came as a surprise to the researchers, who, like their colleagues, had believed that stem cells proliferati
'/>"/>

Contact: Thania Benios
tbenios@rockefeller.edu
212-327-7146
Rockefeller University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Draining away brains toxic protein to stop Alzheimers
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
4. Emory researchers identify signaling protein for multiple myeloma
5. Human C-reactive protein regulates myeloma tumor cell growth and survival
6. Lowering Blood Protein Wont Help Kidney Patients
7. Blood protein detects lung cancer, even at earliest stage
8. Natural Protein Could Help Spot, Treat Liver Cancer
9. Heat shock proteins are co-opted for cancer
10. How adhesive protein causes malaria
11. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... new study by researchers from the Medical College of ... utilization for pain and other sickle cell disease complications ... of both providers and patients were also identified. ... assistant professor of pediatrics at the Medical College and ... will be presented at the American Society of Hematology ...
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/5/2009)... in a phase 1/2 clinical trial that it ... patients newly diagnosed with multiple myeloma, a cancer of ... Dana-Farber Cancer Institute. , Partial responses or better were ... the drug combination in the multi-center study, with 74 ... the phase 2 population, reports Paul G. Richardson, MD, ...
(Date:12/5/2009)... Babies, This Type of Blood Cancer Is Most Challenging-- ... Pediatric oncologists have identified specific genes, dubbed partner ... often-fatal form of leukemia in infants. By more accurately ... which infants may benefit from particular treatments. ,, ...
(Date:12/5/2009)... Center helps companies develop and test their cleaning processes. The technology ... of industries and solve problems for customers relating to cleaning parts, ... ... 2009 -- Midbrook, Inc , a Jackson, MI-based company, is ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... According to a recent study conducted by researchers at ... lead to a rise of certain// chemicals in the ... brain and nerve cell damage. This increase of chemicals ... and symptoms of lasting neurological damage. ,This ...
... published in PLoS Medicine online says that the life expectancy ... an Asian-American woman may live// two decades longer than an ... evidence is really quite clear that most of the gap ... young and middle-aged adult men and women and most of ...
... Sreemathy today visited the community health centre at Vizhinjam and ... of viral fever//. ,"In Tamil Nadu, the number ... managed to prevent the fever spreading further along the coast," ... day in August, but on Saturday the number was just ...
... the safest pain medication? Many people with osteoarthritis ... the painkillers called COX-2 inhibitors// to increased heart ... from a COX-2 drug to other medications, including ... and naproxen. But although NSAIDs are effective at ...
... the positive influence of having a baby and its benefits ... this research seem to suggest that women who are childless ... lives and may even face early death. ,According ... age are 20% more likely to die than their contemporaries, ...
... saw the conclusion of the first of a wave of ... as Wyeth defended// its hormone replacement therapy Prempro against claims ... ,Zoe Littlepage, an attorney for plaintiff Linda Reeves, told the ... was negligent in not testing the drug and not knowing ...
Other Medicine News:Health News:Punch-Drunk Effect- Every blow matters 2
(Date:12/4/2009)... SAN DIEGO, Calif., Dec. 4 Suneva Medical, a ... of Philip Ranker as Vice President and Chief Financial ... all Suneva Medical,s general and administrative functions including finance, ... will also serve on the Company,s senior management team. ...
(Date:12/4/2009)... HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced the ... by PennWell Corporation , a leader in ... dentistry. The course focuses on patient views ...
(Date:12/4/2009)... 4 Bayer Diabetes Care today announced the three grand ... Nick Jonas, of the Jonas Brothers, selected the winning video ... The grand prize is an in-person meeting today with Nick. ... like Nick, are: Caleb, age 6, from Danbury, CT, who ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Without Job Stress Retirees Sleep Better 60756 1Without Job Stress Retirees Sleep Better 60756 2PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 1PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 2PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 3PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 4PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 5Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 1Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 2Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 3Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 4
... And Japanese Study Suggests the Drug Improves Memory, ... Institute announced today that it has received positive,preliminary ... testing a,promising new drug application for the treatment ... announced in,September, is the first human clinical study ...
... /PRNewswire/ -- DiObex,Inc., a privately- held biopharmaceutical ... treat metabolic diseases, today,announced positive phase 2a ... Inhibitor. , In a recently completed multi-center, ... were,treated for two weeks to evaluate the ...
Other Medicine Technology:Sarasota's Roskamp Institute Announces Positive Safety Data in,Human Clinical Study for Alzheimer's Disease 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: